Qingjiang Hu

14PUBLICATIONS
26CO-AUTHORS
Autonomic nervous systemPredictive and prognostic markersHaematological tumoursCancer geneticsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 30, 2026
NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2.

|Jun 09, 2026
Exploring plasma cell-free RNA biomarkers for predicting immune checkpoint inhibitor efficacy in gastric cancer: a translational sub-study of the KSCC VOYAGER phase II trial.

|Apr 27, 2026
TONSL Promotes Hepatocellular Carcinoma Progression by Inhibiting Apoptosis Through Homologous Recombination Repair.

|Mar 09, 2026
Intratumoral <i>Fusobacterium nucleatum</i> Drives Cancer-Associated Fibroblasts Enrichment and Immune Exclusion in Esophageal Squamous Cell Carcinoma.

Takashi Ofuchi, Qingjiang Hu, Kazuki Omachi

|Nov 26, 2024
The clinical significance of signal regulatory protein alpha expression in the immune environment of gastric cancer.

Yasushi Tanaka, Qingjiang Hu, Tetsuro Kawazoe

|Aug 14, 2023
A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report.

Shinichiro Ikeda, Qingjiang Hu, Keita Natsugoe

Pageof 3

Frequent Collaborators

5 joint publications

Koshi Mimori

3 joint publications

Eiji Oki

2 joint publications

Tomohiko Ikehara

2 joint publications

Akinori Tsujimoto